BF Resp Oncology SRL
BF Resp Oncology reported total assets of 434,641 € at the end of the 2025 financial year (annual accounts filed with the NBB on 25 Jul 2026).
By total assets for 2025, BF Resp Oncology ranks in the top half of the 15,434 companies in its sector (NACE 8622) in Belgium that filed accounts for that financial year. Largest companies in the sector →
The score of BF Resp Oncology shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Accounts of the company itself (not consolidated).
Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
BF Resp Oncology's annual accounts
| 2025 | |
|---|---|
| Net result | 317,166 € |
| Equity | 319,166 € |
| Cash | 204,857 € |
| EBITDA | 420,911 € |
| Total assets | 434,641 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 25 Jul 2026
BF Resp Oncology's financial analysis
- Solvency73.4%sector median: 72.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of BF Resp Oncology
BF Resp Oncology's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 1013.959.311
- VAT number
- BE1013959311
- Peppol
- Registered · 0208:1013959311 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 23 Sep 2024
- Registered office
- 3090 Overijse
- Latest accounts
- 2025 · filed on 25 Jul 2026
- Activity
- Medical specialists activities (NACE 86220)
BF Resp Oncology (SRL) has been based in Overijse since 2024, active in: medical specialists activities. For 2025, it reports a net profit of 317,166 € and equity of 319,166 €; its revenue is not published. Its solvency stands at 73.4%, above the median of its sector (72.2%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to BF Resp Oncology
Companies in the same business, of comparable size and area, outside its group.
- I.D.Neuro Medical specialists activities Brussels · balance sheet 435,683 €
- Docteur Andreevscaia Olga - Dermatologue Medical specialists activities Namur · balance sheet 433,324 €
- DR. Yves GASPAR Medical specialists activities Verviers · balance sheet 432,625 €
- Vdwmedskin Medical specialists activities Oud-Heverlee · balance sheet 434,591 €
- Dr. Neil Jarvis, orthopedist Medical specialists activities Hove · balance sheet 434,355 €
- Claravista new Medical specialists activities La Hulpe · balance sheet 434,306 €
- Dorian Van Belle Medical specialists activities Gembloux · balance sheet 434,018 €
- LABA Medical specialists activities Ottignies-Louvain-la-Neuve · balance sheet 435,326 €
Frequently asked questions about BF Resp Oncology
What is the revenue of BF Resp Oncology?
BF Resp Oncology files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of BF Resp Oncology?
In Belgium, the VAT number is the company number prefixed with BE: BE1013959311 for BF Resp Oncology, if the company is VAT-registered. Its company number (CBE) is 1013.959.311.
Where is the registered office of BF Resp Oncology?
According to the CBE register, the registered office of BF Resp Oncology is in 3090 Overijse.
What is the equity of BF Resp Oncology?
At the close of the 2025 financial year, the equity of BF Resp Oncology amounts to 319,166 €, a solvency of 73.4% of total assets.
Who manages BF Resp Oncology?
The register lists 1 active mandates at BF Resp Oncology. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
How large is BF Resp Oncology within its sector?
By total assets for 2025, BF Resp Oncology ranks in the top half of the 15,434 companies in its sector (NACE 8622) in Belgium that filed accounts for that financial year.
The full file of BF Resp Oncology
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →